Dr. Jeffrey J. Wiegers is a double board-certified anesthesiologist and fellowship-trained interventional pain management physician specializing in regenerative and biologic medicine. His work integrates advanced interventional techniques, precision diagnostics, and emerging cellular and molecular therapies to address chronic pain, musculoskeletal degeneration, and complex inflammatory conditions.
Dr. Wiegers earned his undergraduate degree from the University of Missouri–Columbia, where he studied psychology and conducted neuroscience research focused on beta-adrenergic modulation of performance and serotonergic signaling, including functional MRI characterization of 5-HTT receptor activity. He received his Doctor of Medicine from the University of Missouri–Kansas City School of Medicine and developed an early interest in the translational application of ultrasound technology in clinical medicine. During medical training, he collaborated with the anesthesiology department at UCLA to support the development of novel ultrasound training and implementation protocols.
He completed his anesthesiology residency at Cedars-Sinai Medical Center in Los Angeles, where he served as Chief Resident, followed by advanced fellowship training in Interventional Pain Management at Cedars-Sinai. His clinical and research work during this period included investigations into ketamine-based therapeutics and complex pain physiology, further shaping his interest in neuromodulation, pharmacology, and regenerative strategies.
Dr. Wiegers’ current clinical focus centers on advanced interventional regenerative therapies, including biologics, cellular signaling approaches, and ultrasound-guided procedures designed to restore tissue function and reduce reliance on symptom-suppressive care. He is particularly interested in the intersection of pain, inflammation, tissue degeneration, and systemic physiologic resilience, applying a systems-level framework to patient care.
He currently practices at BioReset Medical, where he treats patients from around the world using individualized, evidence-informed regenerative and interventional protocols. In parallel, he remains on staff at Cedars-Sinai Medical Center, where he collaborates on stem cell research and the development of emerging regenerative therapies. Dr. Wiegers is committed to advancing the clinical translation of regenerative medicine and helping redefine how chronic pain and degenerative disease are treated—shifting care toward restoration, durability, and long-term functional health.